[144] RESMED INC SEC Filing

Rhea-AI Filing Summary

ResMed Inc. filed a Form 144 disclosing a proposed sale of 4,876 common shares on the NYSE with an aggregate market value of $1,381,956.16, and 146,414,839 shares outstanding listed. The filing shows the securities were acquired on 10/07/2025 under an option granted 11/16/2022, and the proposed sale date is 10/07/2025. The broker named is Fidelity Brokerage Services LLC in Smithfield, RI. The filer certifies there is no undisclosed material adverse information and reports no securities sold in the past 3 months.

Positive

• Transparent disclosure of the proposed sale under Rule 144 with broker and dates
• No sales in past 3 months, simplifying aggregation rules for this notice

Negative

• Insider sale of 4,876 shares with aggregate value $1,381,956.16 could be viewed negatively by some investors

Insights

Securities Compliance Analyst

TL;DR: Filing documents an insider sale under Rule 144 with clear acquisition and sale dates.

The notice reports a proposed sale of 4,876 common shares via Fidelity Brokerage Services LLC with an aggregate market value of $1,381,956.16. The securities are shown as acquired on 10/07/2025 tied to an option granted 11/16/2022, indicating the sale is linked to option exercise or similar transaction.

Compliance depends on satisfaction of Rule 144 conditions (holding period, public information, volume limits). The signer affirms no undisclosed material adverse information and reports no sales in the past 3 months. Watch for trade settlement and any concurrent Section 16 filings that may be required within the statutory timeframe.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4876	1381956.16	146414839	10/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/07/2025	Option Granted 11/16/2022	Issuer			4876	10/07/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did ResMed (RMD) disclose on Form 144?

The filing discloses a proposed sale of 4,876 common shares on the NYSE with aggregate market value $1,381,956.16 and an approximate sale date of 10/07/2025.

Who is the broker handling the proposed sale for RMD?

The broker listed is Fidelity Brokerage Services LLC located at 900 Salem Street, Smithfield, RI.

When were the shares being sold acquired according to the filing?

The securities are shown as acquired on 10/07/2025 and linked to an option granted 11/16/2022.

Does the filer report other sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

What certification does the filer make about material information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.